GSA CAPITAL PARTNERS LLP - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 85 filers reported holding ANTARES PHARMA INC in Q2 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$58,000
-93.8%
14,150
-94.5%
0.01%
-91.6%
Q3 2021$934,000
-10.9%
256,622
+6.8%
0.10%
-19.5%
Q2 2021$1,048,000
+158.8%
240,303
+143.7%
0.12%
+76.1%
Q1 2021$405,000
+34.1%
98,620
+30.2%
0.07%
+36.7%
Q4 2020$302,000
+184.9%
75,726
+92.1%
0.05%
+172.2%
Q3 2020$106,000
-87.4%
39,419
-89.0%
0.02%
-91.5%
Q1 2020$844,000
+848.3%
357,789
+1794.7%
0.21%
+2020.0%
Q4 2019$89,000
-18.3%
18,884
-41.9%
0.01%
-33.3%
Q3 2019$109,000
+113.7%
32,496
+71.9%
0.02%
+150.0%
Q4 2018$51,000
-90.1%
18,903
-91.9%
0.01%
-77.8%
Q1 2018$513,000
+12.7%
233,300
+2.1%
0.03%
-3.6%
Q4 2017$455,000
-22.9%
228,500
+25.5%
0.03%
-30.0%
Q3 2017$590,000
-9.4%
182,075
-9.9%
0.04%
-4.8%
Q2 2017$651,000
+135.0%
202,160
+97.6%
0.04%
+281.8%
Q1 2015$277,000
+177.0%
102,316
+162.2%
0.01%
+57.1%
Q4 2014$100,000
+13.6%
39,016
-18.7%
0.01%
+40.0%
Q3 2014$88,00048,0000.01%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders